These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8148464)

  • 21. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
    Lipcsey M; Tenhunen J; Sjölin J; Frithiof R; Bendel S; Flaatten H; Kawati R; Kuitunen A; Tønnessen TI; Rubertsson S
    Trials; 2016 Dec; 17(1):587. PubMed ID: 27931259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology of septic shock and implications for therapy.
    Barron RL
    Clin Pharm; 1993 Nov; 12(11):829-45. PubMed ID: 8161370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endotoxin in septic shock.
    Hoffman WD; Natanson C
    Anesth Analg; 1993 Sep; 77(3):613-24. PubMed ID: 8368563
    [No Abstract]   [Full Text] [Related]  

  • 25. Sepsis and SIRS.
    Bone RC
    Nephrol Dial Transplant; 1994; 9 Suppl 4():99-103. PubMed ID: 7800276
    [No Abstract]   [Full Text] [Related]  

  • 26. The last round against bacterial infections?
    Marget W
    Infection; 1990; 18(4):197-9. PubMed ID: 2210849
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current concepts in the pathogenesis and treatment of abortion and septic shock. II. The physiopathological bases and outlook in the management of septic shock].
    Figueroa Damian R; Arredondo García JL
    Ginecol Obstet Mex; 1993 Dec; 61():337-43. PubMed ID: 8119603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sepsis and septic shock.
    Zanetti G; Baumgartner JD; Glauser MP
    Schweiz Med Wochenschr; 1997 Mar; 127(12):489-99. PubMed ID: 9106949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Monoclonal antibodies in the treatment of sepsis and septic shock].
    Torrabadella de Reynoso P; Salgado Remigio A; Peracaula Picart R
    Med Clin (Barc); 1992 Dec; 99(20):784-92. PubMed ID: 1460952
    [No Abstract]   [Full Text] [Related]  

  • 30. Adjunctive therapy for septic shock: a review of experimental approaches.
    Lynn WA; Cohen J
    Clin Infect Dis; 1995 Jan; 20(1):143-58. PubMed ID: 7727640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic interventions aimed at preventing the biologic effects of endotoxin.
    Sable CA; Wispelwey B
    Infect Dis Clin North Am; 1991 Dec; 5(4):883-98. PubMed ID: 1783774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Septic shock in newborn infants].
    Mancilla-Ramírez J
    Bol Med Hosp Infant Mex; 1992 Nov; 49(11):766-76. PubMed ID: 1466777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Mitaka C; Tomita M
    Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endotoxins of gram-negative bacteria, cytokines and the concept of septic shock: present state of the problem].
    Beloborodov VB; Dzheksenbaev OSh
    Anesteziol Reanimatol; 1991; (4):41-3. PubMed ID: 1952239
    [No Abstract]   [Full Text] [Related]  

  • 35. A controlled trial of HA-1A in a canine model of gram-negative septic shock.
    Quezado ZM; Natanson C; Alling DW; Banks SM; Koev CA; Elin RJ; Hosseini JM; Bacher JD; Danner RL; Hoffman WD
    JAMA; 1993 May; 269(17):2221-7. PubMed ID: 8474201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shock attributable to bacteremia and endotoxemia in cattle: clinical and experimental findings.
    Cullor JS
    J Am Vet Med Assoc; 1992 Jun; 200(12):1894-902. PubMed ID: 1639694
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in anti-endotoxin-IgG antibody and endotoxaemia in three cases of gram-negative septic shock.
    Barclay GR; Scott BB; Wright IH; Rogers PN; Smith DG; Poxton IR
    Circ Shock; 1989 Oct; 29(2):93-106. PubMed ID: 2582583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of septic shock: implications for prevention and treatment.
    Calandra T
    J Chemother; 2001 Nov; 13 Spec No 1(1):173-80. PubMed ID: 11936363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of septic shock.
    Lillehei RC; Dietzman RH; Movsas S; Bloch JH
    Mod Treat; 1967 Mar; 4(2):321-46. PubMed ID: 5341883
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibodies to tumour necrosis factor in the treatment of severe sepsis: rationale and early clinical experience.
    Cohen J
    Prog Clin Biol Res; 1991; 367():187-96. PubMed ID: 1924427
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.